You are here: Industry Insights > COVID-19

News List

New ￡1.3m national research programme to evaluate coronavirus tests pharmatimes
June 30, 2020
A multicentre national programme of research has been launched to evaluate how new diagnostic tests for COVID-19 perform in hospitals, general practices and care homes, in the hope of making testing quicker, more convenient and more accurate.
Existing drugs can prevent SARS-CoV-2 from hijacking cells worldpharmanews
June 30, 2020
An international team of researchers has analysed how SARS-CoV-2, the virus that causes COVID-19, hijacks the proteins in its target cells.
Ampio to Start First Clinical Trial in COVID-19 Program americanpharmaceuticalreview
June 30, 2020
Ampio Pharmaceuticals is developing therapies for patients infected with the SARS-CoV-2 virus (COVID-19).
FDA Issues Guidance for Clinical Trials during the COVID-19 Public Health Emergency americanpharmaceuticalreview
June 30, 2020
The U.S. Food & Drug Administration (FDA) has issued a guidance for industry entitled, “Statistical Considerations for Clinical Trials During the COVID-19 Public Health Emergency.”
Common cancer treatments do not worsen COVID-19 infection, study finds europeanpharmaceuticalreview
June 30, 2020
A study has found that chemotherapy and surgery do not correlate with worse COVID-19 outcomes for cancer patients, whereas taking immune checkpoint inhibitors does.
Gilead sets Covid-19 drug candidate remdesivir price at $390 per vial pharmaceutical-technology
June 30, 2020
Gilead Sciences has set the price of its investigational Covid-19 drug remdesivir at $390 per vial for the US and governments of other developed countries.
Expect to launch 25 products in US this fiscal: Dr Reddy’s expresspharma
June 30, 2020
As of March 31, 2020, the company has 99 cumulative filings pending for approval with the US Food and Drug Administration (US FDA), including two new drug approvals (NDAs).
Roche not yet meeting demand for molecular COVID-19 tests, chairman says expresspharma
June 30, 2020
Demand for its antibody tests, which determine whether people have ever been infected with the coronavirus, can be met as Roche has been boosting production, he said.
CHMP backs approval of remdesivir as COVID-19 treatment pharmatimes
June 29, 2020
The EMA’s human medicines committee (CHMP) is backing approval of Gilead's remdesivir – under the brand name Veklury – for the treatment of COVID-19 in patients aged 12 years and over with pneumonia who require supplemental oxygen.
Eight medicines leap towards EU approval pharmatimes
June 29, 2020
The European Medicines Committee's human medicines committee (CHMP) has backed approval of eight new medicines across a range of indications.